May 27, 2022
Video
Before closing out their discussion on treatment for EGFR Exon 20–Positive NSCLC, experts discuss prominent unmet needs in this setting.
May 20, 2022
A shared discussion on the importance of enrolling in clinical trials for EGFR exon 20–positive NSCLC and improving access to novel therapy for patients.
A focused conversation on how a patient can maintain and improve quality of life while receiving therapy for non–small cell lung cancer.
May 13, 2022
Comprehensive discussion on support for patients receiving therapy for NSCLC, ranging from care team members to education materials to support groups.
FDA Approves Ziihera for Some With Biliary Tract Cancer
PD-L1, KIM-1 Levels May Predict Kidney Cancer Response to Opdivo, Yervoy
Donor Lymphocyte Infusion May Improve Survival in R/R MDS
It's OK Not to Have Full Holiday Spirit During Cancer